MS
PROK icon

Maven Securities’s ProKidney PROK Stock Holding History

Maven Securities’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500,000
Closed -$4.9M – 1106
2021
Q3 		$4.9M Hold
500,000
– – 0.16% 95
2021
Q2 		$5.05M Buy
+500,000
New +$5.05M 0.2% 86

Other funds holding PROK

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return

Maven Securities's PROK Position: Q4 2021 in Review

Maven Securities sold out of ProKidney (PROK) in Q4 2021, closing a stake of 500,000 shares — an estimated $4.9M sold.

Maven Securities first reported a position in PROK in Q2 2021 and held it in 2 quarters. The position peaked at $5.05M in Q2 2021. 90 funds tracked by Wall St. Rank hold PROK as of Q4 2021.

  • Maven Securities reported no remaining ProKidney position as of Q4 2021 after selling out during the quarter.
  • Maven Securities sold 500,000 ProKidney shares in Q4 2021, an estimated $4.9M.
  • Maven Securities first reported a position in ProKidney in Q2 2021 and held it in 2 quarters.
  • Maven Securities's ProKidney position peaked at $5.05M in Q2 2021.
  • 90 funds tracked by Wall St. Rank held ProKidney as of Q4 2021.

Based on Maven Securities's 13F filing for Q4 2021, filed 14 Feb 2022.